Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States

BACKGROUND: Data on the clinical and economic burden of eosinophilic granulomatosis with polyangiitis (EGPA) are limited. OBJECTIVE: To assess the real-world clinical and economic outcomes of patients diagnosed with EGPA vs patients with asthma (present in > 90% of EGPA cases) receiving treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Christopher F, Blauer-Peterson, Cori, Mao, Jianbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394225/
https://www.ncbi.nlm.nih.gov/pubmed/34165321
http://dx.doi.org/10.18553/jmcp.2021.21002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394225/
https://www.ncbi.nlm.nih.gov/pubmed/34165321
http://dx.doi.org/10.18553/jmcp.2021.21002

Ejemplares similares